Pre-Market Earnings Report for August 11, 2025 : B, B, FNV, MNDY, ROIV, LEGN, TDS, USM, KYMR, RUM, DOLE, SPHR

On August 11, 2025, several companies are set to report Q2 earnings, presenting a mixed outlook across sectors. Gold miners Barrick Mining (B) and Franco-Nevada (FNV) are forecast to show strong EPS growth (approx. +47% YoY) with higher P/E ratios indicating robust growth expectations. Internet software firm monday.com (MNDY) projects a 29.17% EPS decrease despite a history of significant beats, while carrying a high P/E of 224.91, implying substantial future growth. Conversely, biomedical companies like Roivant Sciences (ROIV), Legend Biotech (LEGN), and Kymera Therapeutics (KYMR) are largely forecasting negative EPS, highlighting varied performance and growth trajectories within the upcoming earnings cycle.

Analysis

The upcoming earnings reports for August 11, 2025, reveal significant divergence across sectors. In the gold mining industry, both Barrick Mining (B) and Franco-Nevada (FNV) are positioned for substantial year-over-year EPS growth, with forecasts of +46.88% and +46.67% respectively. Their forward P/E ratios of 11.77 and 36.17 are considerably higher than the industry average of 2.40, indicating strong market expectations for future earnings outperformance. In contrast, the technology sector presents a mixed picture. monday.com (MNDY) is forecast for a 29.17% EPS decline, yet it has a history of dramatic earnings beats—including a 1200% surprise in the first calendar quarter—and carries a very high forward P/E of 224.91, suggesting investors are pricing in substantial long-term growth despite the short-term projection. The biomedical sector appears weak, with Roivant (ROIV), Legend Biotech (LEGN), and Kymera (KYMR) all forecasting negative EPS, highlighted by LEGN's projected 340% YoY EPS decrease. Kymera also presents a notable risk profile with a "days to cover" exceeding 10, signaling significant short interest. Meanwhile, telecom companies Telephone and Data Systems (TDS) and U.S. Cellular (USM) show projected YoY EPS improvements but are coming off significant misses in the prior quarter, raising concerns about execution and forecast reliability.

Key Decisions for Investors

• Given the strong consensus EPS growth forecasts for Barrick Mining and Franco-Nevada, investors could view these as bullish plays in the commodities space, but should be aware that their high P/E ratios relative to the industry suggest lofty expectations are already priced in.
• Caution is advised for biomedical stocks like Roivant, Legend, and Kymera due to their negative EPS forecasts; specifically, Kymera's high short interest, with 'days to cover' exceeding 10, points to elevated risk and potential for significant volatility around the earnings release.
• monday.com presents a high-risk, high-reward scenario; investors should note the conflict between its forecast 29.17% EPS decline and its historical tendency for massive earnings beats, making it a potential candidate for a large post-earnings price swing.
• For telecom names like TDS and USM, it is prudent to weigh the positive YoY earnings growth forecasts against their significant misses in the previous quarter, suggesting investors should look for confirmation of operational consistency before building a position.